arrow
J

John J. Krais

Washington University School of Medicine
H指数:20
被引数:2,081

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TET2 loss triggers ssDNA gap accumulation and heightened PARP inhibitor sensitivity

TET2缺失引发单链DNA缺口积累和增强的PARP抑制剂敏感性

2026-09-120
OA
ATF4 coordinates amino acid and nucleotide synthesis with selective protein translation to ensure proper DNA replication timing in leukemia cells

ATF4通过协调氨基酸和核苷酸合成与选择性蛋白质翻译,以确保白血病细胞中DNA复制的正确时间

2026-06-200
OAAI
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
2024-08-050
OAAI
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
2024-04-053
OAAI
4′-Ethynyl-2′-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress
2023-12-080
PRE
Genetic separation of Brca1 functions reveal mutation-dependent Polθ vulnerabilities

Brca1功能的遗传分离揭示了依赖于突变的pol θ 漏洞

2023-11-246
OAAI
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency (vol 81, pg 3128, 2021)

复制缺口是BRCA缺乏的PARP抑制剂合成致死率的关键决定因素 (第81卷,3128页,2021)

2021-08-01113
OA
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency

复制缺口是PARP抑制剂合成致死率与BRCA缺乏症的关键决定因素

2021-08-01108
OAAI
Replication Gaps Underlie BRCA Deficiency and Therapy Response

复制缺口是BRCA缺乏和治疗反应的基础

2021-03-01129
OAAI
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance (vol 24, 3513, 2018)
2018-10-0120
OAAI
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
2018-09-28210
OAAI
BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance
2018-09-0166
OAAI